Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · IEX Real-Time Price · USD
4.690
+0.010 (0.21%)
At close: Jul 19, 2024, 12:00 AM
4.640
-0.050 (-1.07%)
Pre-market: Jul 22, 2024, 9:04 AM EDT
Capricor Therapeutics Employees
As of December 31, 2023, Capricor Therapeutics had 102 total employees, including 101 full-time and 1 part-time employees. The number of employees increased by 28 or 37.84% compared to the previous year.
Employees
102
Change (1Y)
28
Growth (1Y)
37.84%
Revenue / Employee
$265,669
Profits / Employee
-$238,366
Market Cap
149.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
Lifecore Biomedical | 459 |
Quantum-Si incorporated | 159 |
ProQR Therapeutics | 157 |
OptiNose | 132 |
Alpha Tau Medical | 121 |
Kodiak Sciences | 111 |
Vaxart | 109 |
CAPR News
- 26 days ago - CORRECTION: Capricor Therapeutics - GlobeNewsWire
- 27 days ago - Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy - GlobeNewsWire
- 5 weeks ago - Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway - GlobeNewsWire
- 5 weeks ago - Capricor Advances in DMD Therapy With Positive Study Data - Benzinga
- 2 months ago - Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting - GlobeNewsWire
- 2 months ago - Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences - GlobeNewsWire
- 2 months ago - Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13 - GlobeNewsWire